MIMT1 and breast cancer: At the same time, MDA-MB-231 breast cancer cells treated with MOXI and MIM1 in two-component models for 48 h demonstrated a significant increase in the percentage of depolarized cells, as well as fragmented DNA up to 91% and 54%, respectively.